NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Massachusetts General Hospital
Conditions: Heart Failure
Interventions: AMAZE (TM) Disease Management Platform
Countries: United States
AMAZE™ is a disease management platform (DMP) designed to educate patients about heart failure, help engage them in healthy behaviors and assist them in taking their medications as prescribed. This study will assess whether the AMAZE™ smartphone-based application ("app") can help heart failure patients take better care of themselves after discharge from an inpatient heart failure admission at Massachusetts General Hospital (MGH). The primary objective is to demonstrate feasibility and perceived value of the AMAZE™ platform in clinical practice. The study will also explore whether the use of the AMAZE™ platform for 60 days post-discharge leads to a reduction in hospital readmission, emergency department, urgent care and unexpected ambulatory care visits. The impact of the AMAZE™ platform on participant reported quality of life outcomes and perception of overall medical care will also be examined.
Sex: ALL
Age: 21 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Inclusion Criteria: Adults (\>21 years) admitted to MGH Cardiology services (Ellison 10 and 11) with a primary diagnosis of heart failure \[HFrEF(\<40%), HFmEF(40-49%) HFpEF(≥50%)\] (or to BWH Cardiology services for BWH EHR-based controls) Has a smartphone or iPad and is willing to enter health metrics into DMP App and email willing to use for the study Access to the internet Established or with plan to establish primary cardiologist at MGH (or at BWH for BWH EHR-based controls) Discharged home or to self-care (with or without home services) Exclusion Criteria: Moderate or severe cognitive impairment Non-English-speaking Palliative management only (comfort measures) Does not own a smartphone or iPad (not considered for EHR-based controls) Incarcerated
- Boston, Massachusetts, United States